11-94380763-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016540.4(GPR83):c.658G>T(p.Val220Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000046 in 1,607,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016540.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR83 | NM_016540.4 | c.658G>T | p.Val220Leu | missense_variant | 4/4 | ENST00000243673.7 | |
GPR83 | NM_001330345.2 | c.532G>T | p.Val178Leu | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR83 | ENST00000243673.7 | c.658G>T | p.Val220Leu | missense_variant | 4/4 | 1 | NM_016540.4 | P1 | |
GPR83 | ENST00000539203.2 | c.532G>T | p.Val178Leu | missense_variant | 3/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151390Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 248130Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133882
GnomAD4 exome AF: 0.0000474 AC: 69AN: 1456372Hom.: 0 Cov.: 33 AF XY: 0.0000401 AC XY: 29AN XY: 723950
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151390Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73906
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2023 | The c.658G>T (p.V220L) alteration is located in exon 4 (coding exon 4) of the GPR83 gene. This alteration results from a G to T substitution at nucleotide position 658, causing the valine (V) at amino acid position 220 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at